BIO Announces Business Forum Company Presentations at the 2010 BIO International Convention

WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) announced the Business Forum company presentations to take place at the 2010 BIO International Convention. The global event for biotechnology will be held May 3-6 in Chicago, Ill. at McCormick Place.

Company presentations will provide valuable insight to the stories, pipelines, and partnering objectives of participating domestic and international companies in 35 different therapeutic and industry tracks, including leading biotechnology & pharmaceutical companies, oncology, cardiology, CNS/neurology, diagnostics, gene/cell therapy, infectious diseases and immunology.

“Currently, we have more than 130 companies scheduled to present at the BIO Business Forum, more than 40 percent of which are international,” said Alan Eisenberg, Executive Vice President of Emerging Companies & Business Development at BIO. “Given the current economic climate, collaborations from the pharmaceutical and biotechnology sector are more important than ever. These presentations and networking opportunities can lead to future collaborations down the road, resulting in innovations in research, medicines and new technologies.”

In addition to company presentations, BIO Business Forum attendees can schedule one-on-one meetings using BIO One-on-One PartneringTM and discuss potential business opportunities through numerous formal and informal networking opportunities. BIO currently expects more than 14,000 meetings among biotechnology and pharmaceutical companies, academic institutions, and investors from around the world. Many companies, including sanofi pasteur, have initiated partnerships after attending the BIO Business Forum.

“This event is a very important component of sanofi pasteur’s partnering efforts,” said Dr. Allan Jarvis, vice president of corporate development at sanofi pasteur. “This year we expect to be booked solid again in our partnering presentations. We believe that this is a great venue to develop successful partnerships to develop vaccines for global health.”

Opportunities are still available for companies interested in presenting at the Business Forum at the 2010 BIO International Convention. Applications will be accepted until April 12, 2010. To request a presentation slot, visit: http://business-forum.bio.org/bf/2010/presentations/presentationapp.asp.

 

2010 Presenting Companies:

 
7TM Pharma A/S
Aastrom Biosciences Inc. (ASTM)
Addex Pharmaceuticals (SIX: ADXN)
Adolor Corp. (ADLR)
Affectis Pharmaceuticals AG
Allon Therapeutics Inc. (TSE: NPC)
Altea Therapeutics Corporation
Amarin Corp. PLC (AMRN)
Amnestix, Inc
Amylin Pharmaceuticals (AMLN)
AstraZeneca (AZN)
Bavarian Nordic A/S (CPH: BAVA)
Bayer HealthCare (ETR: BAYN)
BioGenes GmbH
BiondVax Pharmaceuticals Ltd. (TASE: BNDX)
Bionomics Ltd (ASX: BNO)
BioRealites
BioSante Pharmaceuticals Inc. (BPAX)
Biovest International, Inc. (BVTI)
Boehringer Ingelheim GmbH
BTG PLC (LSE: BGC)
Calistoga Pharmaceuticals
caprotec bioanalytics GmbH
Capstone Therapeutics (CAPS)
Cardio3 Biosciences
Catalyst Biosciences
Cevec Pharmaceuticals GmbH
Champions Biotechnology (CSBR)
CombinatoRx Inc. (CRXX)
Cortex Pharmaceuticals Inc. (CORX)
Crown Bioscience Inc.
CyDex Pharmaceuticals
DBV Technologies
Debiopharm SA
Diamyd Medical AB (STO: DIAM)
DSM Biologics
Elan Drug Technologies (ELN)
Eli Lilly (LLY)
Endocrine Technology, LLC
EpiCept Corporation (EPCT)
Eurand (EURX)
FivePrime Therapeutics, Inc.
Foamix Ltd.
GangaGen Inc.
Genentech
Genfit (EPA: ALGFT)
Genta Inc. (GETA)
GlaxoSmithKline (GSK)
GlycoMimetics
Glycotope GmbH
Golden biotechnology Corp.
HanAll Biopharma Co., Ltd. (SEO: 009420)
Hanmi Pharm. Co., Ltd. (SEO: 008930)
Hematech, Inc.
Hemispherx Biopharma, Inc. (HEB)
Hydra Biosciences
Idera Pharmaceuticals, Inc. (IDRA)
Immunovaccine Inc. (CVE: IMV)
InflammatoRx Inc.
Innovascreen Inc
Inovio Biomedical Corp. (INO)
Isis Pharmaceuticals (ISIS)
KAI Pharmaceuticals
KaloBios Pharmaceuticals
KMT Hepatech, Inc.
Koronis Pharmaceuticals
Lexicon Pharmaceuticals, Inc. (LXRX)
LG Life Sciences (SEO: 068870)
Light Sciences Oncology
LigoCyte Pharmaceuticals.
Logical Therapeutics, Inc.
MacroCure Ltd.
MacroGenics
MDRNA Inc. (MRNA)
Medicago Inc. (MDCGF)
MedImmune
Merck (MRK)
Merck Serono
MethylGene Inc. (TSE: MYG)
Micromet Inc. (MITI)
MolMed S.p.A. (BIT: MLM)
Movetis NV (EBR: MOVE)
NanGenex Inc.
National Institutes of Health
NexBio, Inc
NovaBay Pharmaceuticals, Inc. (NBY)
Novavax Inc. (NVAX)
Novo Nordisk (NVO)
Nuon Therapeutics, Inc.
Nycomed
Ohmx Corporation
Oxygen Biotherapeutics, Inc. (OXBT)
PAION AG (ETR: PA8)
ParinGenix
PDS Biotechnology Corporation
Pluristem Therapeutics, Inc. (PSTI)
PolyMedix, Inc. (PYMX)
Protalix Biotherapeutics Inc. (PLX)
PsychoGenics Inc.
PTC Therapeutics
QRxPharma Limited (ASX: QRX)
Receptos
Regado Biosciences, Inc.
Roche (RHHBY)
RXI Pharmaceuticals Corp. (RXII)
sanofi pasteur
Shionogi (TYO: 5407)
Spectrum Pharmaceuticals Inc. (SPPI)
Synergy Pharmaceuticals, Inc. (SGYP)
Takeda (TYO: 4502)
TenX Biopharma, Inc.
Tolerx
Transgenomic Inc. (TBIO)
Tranzyme Pharma
University of Pittsburgh
Viralytics Ltd (ASX: VLA)
Viventia Biotechnologies, Inc
WuXi AppTec, Inc (WX)
Xenon Pharmaceuticals Inc.
YM BioSciences USA Inc. (YMI)
Zeltia S.A. (MCE: ZEL)
ZIOPHARM Oncology, Inc. (ZIOP)
 
Partnering for Global Health:
 
Aeras Global TB Vaccine Foundation
Bill & Melinda Gates Foundation
Commons Capital
Drugs for Neglected Diseases initiative
Global Alliance for TB Drug Development
International AIDS Vaccine Initiative
Medicines for Malaria Venture
PATH
WHO Special Programme for Research and Training in Tropical Diseases (TDR)


About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.


Be included in official convention coverage - Tag your convention related content, blog posts, photos and videos with:
BIO International Convention: #bio10
BIO Business Forum: #bio1x1
BIO Exhibitors: #bioex
Follow us on Twitter
Listen to our podcasts
Join us on Facebook
Connect with us on LinkedIn
Participate in our Meet-ups
Visit our YouTube Channel
View our photo albums on Flickr


Upcoming BIO Events

BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA

Partnering for Global Health
May 3, 2010
Chicago, IL
McCormick Place Convention Center

BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center

2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL

World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC

BIO India
September 21 - 22, 2010
Hyderabad, India

BIO’s Livestock Biotechnology Summit
September 28-30, 2010
Sioux Falls, SD



CONTACT:

Biotechnology Industry Organization (BIO)
Tracy Krughoff, 202-312-9274
[email protected]

http://convention.bio.org

KEYWORDS:   United States  North America  District of Columbia  Illinois

INDUSTRY KEYWORDS:   Health  Biotechnology  Cardiology  Genetics  Infectious Diseases  Medical Devices  Oncology  Pharmaceutical  Other Health  Research  Science

MEDIA:

Logo
 Logo

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.